Systematic genetic interaction studies identify histone demethylase Utx as potential target for ameliorating Huntington's disease

Huntington's Disease (HD) is a dominantly inherited neurodegenerative disease caused by alterations in the huntingtin gene (htt). Transcriptional dysregulation is an early event in HD progression. Protein acetylation and methylation particularly on histones regulates chromatin structure thereby...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Song Wan
Zsindely Nóra
Faragó Anikó
Marsh Lawrence J.
Bodai László
Dokumentumtípus: Cikk
Megjelent: 2018
Sorozat:HUMAN MOLECULAR GENETICS 27 No. 4
doi:10.1093/hmg/ddx432

mtmt:3308300
Online Access:http://publicatio.bibl.u-szeged.hu/12897
LEADER 02684nab a2200265 i 4500
001 publ12897
005 20201124084554.0
008 180206s2018 hu o 0|| zxx d
022 |a 0964-6906 
024 7 |a 10.1093/hmg/ddx432  |2 doi 
024 7 |a 3308300  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a zxx 
100 1 |a Song Wan 
245 1 0 |a Systematic genetic interaction studies identify histone demethylase Utx as potential target for ameliorating Huntington's disease  |h [elektronikus dokumentum] /  |c  Song Wan 
260 |c 2018 
300 |a 649-666 
490 0 |a HUMAN MOLECULAR GENETICS  |v 27 No. 4 
520 3 |a Huntington's Disease (HD) is a dominantly inherited neurodegenerative disease caused by alterations in the huntingtin gene (htt). Transcriptional dysregulation is an early event in HD progression. Protein acetylation and methylation particularly on histones regulates chromatin structure thereby preventing or facilitating transcription. Although protein acetylation has been found to affect HD symptoms, little is known about the potential role of protein methylation in HD pathology. In recent years, a series of proteins have been described that are responsible for methylating and demethylating histones as well as other proteins. We carried out systematic genetic interaction studies testing lysine and arginine methylases and demethylases in a Drosophila melanogaster HD model. We found that modulating methylation enzymes that typically affect histone positions H3K4, H3K36 or H3K79 had varying effects on HD pathology while modulating ones that typically affect constitutive heterochromatin marks at H3K9 and H4K20 generally had limited impact on HD pathology. In contrast, modulating enzymes acting on the facultative heterochromatin mark at H3K27 had specific effects on HD pathology, with reduction of the demethylase Utx rescuing HTT induced pathology while reducing PRC2 complex core methylase components led to more aggressive pathology. Further exploration of the mechanism underlying the methylation-specific interactions suggest that these lysine and arginine methylases and demethylases are likely exerting their influence through non-histone targets. These results highlight a novel therapeutic approach for HD in the form of Utx inhibition. 
700 0 1 |a Zsindely Nóra  |e aut 
700 0 1 |a Faragó Anikó  |e aut 
700 0 1 |a Marsh Lawrence J.  |e aut 
700 0 1 |a Bodai László  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/12897/1/2018_Song_accepted_manuscript_ddx432_u.pdf  |z Dokumentum-elérés  
856 4 0 |u http://publicatio.bibl.u-szeged.hu/12897/7/Human_molecular_genetics_2018_4_cimlap_tartj.pdf  |z Dokumentum-elérés